Regulatory Framework: UK Radiopharmaceuticals Market Regulation
The UK Radiopharmaceuticals Market Regulation is highly rigorous, managed by the Medicines and Healthcare products Regulatory Agency (MHRA), which oversees all aspects of manufacturing, importation, and licensing. All radiopharmaceuticals must comply with the UK Human Medicines Regulations 2012 and stringent Good Manufacturing Practice (GMP) guidelines, often requiring product-specific...
0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр